The Ottawa Hospital-Integrated Cancer Program
Ottawa, Ontario, K1H-1C4, Canada
NCT Number: NCT00253916
Androgen Deprivation Therapy is a commonly used treatment for men with Prostate Cancer. Unfortunately this can lead to functional decline, fatigue, increased body fatness, loss of lean body tissue and impaired QOL. Previous research has demonstrated the exercise can may reduce fatigue and improve QOL in men on ADT. This study will evaluate whether aerobic versus resistance exercise over a 24 week period of training will reduce morbidity and improve QOL in men receiving radiation plus or minus ADT with curative intent
Looking for future studies?
Notify MeMale
Interventional
Not applicable
Ottawa, Ontario, K1H-1C4, Canada
A total of 220 men with a diagnosis of prostate cancer, scheduled to receive radiation will be recruited. The study is a parallel 3-group design with groups stratified for intended duration of ADT ( greater or less than 12 weeks) and random assignment to aerobic, resistance or Wait List control groups. The dependent variable of interest will fatigue measured at 24 weeks by the 13 item FACT-Fatigue. Dependent variables of secondary interest will be toxicity of radiation, body composition, muscular fitness, cardio-respiratory fitness, metabolic fitness, and prostate specific QOL. All exercise sessions will be performed 3 times per week at the Ottawa Hospital regional Cancer Center
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Aerobic cardiovascular exercise program
Resistance Exercise Program
Time frame: 24 weeks
Time frame: 24 weeks
Ottawa Hospital Research Institute
Other
Exercise in Men Receiving Radiation Therapy for Prostate Cancer: Effects on Fatigue, Toxicity, Body Composition, Muscular Fitness, Cardiorespiratory Fitness and Quality of Life.
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04108208
Genital Diseases, Genital Diseases, Male
Beijing, China
View Trial DetailsNCT03834493
Genital Diseases, Genital Diseases, Male
Mobile, Alabama, United States
View Trial DetailsNCT02854982
Genital Diseases, Genital Diseases, Male
Nîmes, Gard, France
View Trial DetailsNCT03421015
Disease Attributes, Genital Diseases
Lille, France
View Trial Details